BCWORLD PHARM. Co., Ltd. (KOSDAQ:200780)
South Korea · Delayed Price · Currency is KRW 5,270.00
+10.00 (0.19%)
Feb 5, 2026, 3:30 PM KST
BCWORLD PHARM. Revenue
BCWORLD PHARM. had revenue of 19.25B KRW in the quarter ending September 30, 2025, with 9.86% growth. This brings the company's revenue in the last twelve months to 77.04B, up 5.71% year-over-year. In the year 2024, BCWORLD PHARM. had annual revenue of 74.81B, down -0.39%.
Revenue (ttm)
77.04B
Revenue Growth
+5.71%
P/S Ratio
0.63
Revenue / Employee
275.16M
Employees
280
Market Cap
48.83B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 74.81B | -296.36M | -0.39% |
| Dec 31, 2023 | 75.11B | 2.41B | 3.31% |
| Dec 31, 2022 | 72.70B | 10.62B | 17.11% |
| Dec 31, 2021 | 62.08B | 5.05B | 8.85% |
| Dec 31, 2020 | 57.03B | 5.53B | 10.74% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 4.56T |
| Celltrion | 3.90T |
| Sam Chun Dang Pharm. | 220.74B |
| ALTEOGEN | 202.18B |
| MYUNGMOON Pharm co.,Ltd | 193.64B |
| METACARE CO. | 28.10B |
| Tdspharm | 24.56B |
| HASS Corp. | 17.18B |